Form 8-K - Current report:
SEC Accession No. 0001213900-25-034623
Filing Date
2025-04-23
Accepted
2025-04-23 16:15:25
Documents
13
Period of Report
2025-04-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea023930201-8k_biomxinc.htm   iXBRL 8-K 30960
  Complete submission text file 0001213900-25-034623.txt   203877

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phge-20250421.xsd EX-101.SCH 3014
3 XBRL LABEL FILE phge-20250421_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE phge-20250421_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT ea023930201-8k_biomxinc_htm.xml XML 3647
Mailing Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003 972 723942377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 25861667
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)